Skip to main content
. 2019 Jul 26;7:309. doi: 10.3389/fped.2019.00309

Table 3.

Neonatal outcomes.

Controls newborns (n = 85) SSRIs newborns (n = 42) p-value
Neonatal sex NS
  Female 41 (48.2%) 22 (52.4%)
  Male 44 (51.8%) 20 (47.6%)
Preterm 4 (4.7%) 3 (7.1%) NS
Neonatal weight (gr) 3303.8 ± 431.0 3148.9 ± 593.5 NS
LBW 1 (1.2%) 6 (14.3%) 0.011
APGAR score at 1′ mean 9.7 ± 0.8 9.0 ± 1.3 0.006*
APGAR score at 1′ 0.017
  6 0 3 (7.1%)
  7 2 (2.4%) 4 (9.5%)
  8 3 (3.5%) 5 (11.9%)
  9 12 (14.1%) 8 (19.0%)
  10 68 (80.0%) 22 (52.4%)
APGAR score at 5′ mean 10 ± 0.2 9.7 ± 0.6 0.023*
APGAR score at 5′ 0.013
  8 0 3 (7.1%)
  9 3 (3.5%) 6 (14.3%)
  10 82 (96.5%) 33 (78.6%)
APGAR score at 1′ <7 0 3 (7.1%) 0.069
UA pH 7.3 ± 0.1 7.3 ± 0.1 NS
UA BE −2.9 ± 3.6 −2.1 ± 4.9 NS

Data are presented as mean (± SD) or as number of women (%).

SSRIs, selective serotonin reuptake inhibitors.

Preterm, newborns of < 37 gestational age.

LBW, low birth weight. Birth weight of a liveborn infant of <2,500 g regardless of gestational age.

UA, umbilical artery; BE, base excess.

*

Student's t-test.

Pearson's chi-squared test (χ2).